Enalapril does not alter adhesion molecule levels in human endotoxemia

Shock

Volumn 19, Issue 5, 2003, Pages 448-451

  Graninger, Monika ^a   Marsik, Claudia ^a   Dukic, Tanja ^a   Wagner, Oswald F ^a   Blann, Andrew D ^b   Jilma, Bernd ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Angiotensin converting enzyme; E selectin; Endotoxin; ICAM; Randomized controlled trial

Indexed keywords

CD11 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENALAPRILAT; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTOXIN; INTERCELLULAR ADHESION MOLECULE 1; LIPOPOLYSACCHARIDE; PADGEM PROTEIN; PARACETAMOL; PLACEBO; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENDOTOXEMIA; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; MALE; MONOCYTE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; UPREGULATION;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CELL ADHESION MOLECULES; DOUBLE-BLIND METHOD; ENALAPRIL; ENDOTHELIUM, VASCULAR; ENDOTOXEMIA; HUMANS; INFUSIONS, INTRAVENOUS; LIPOPOLYSACCHARIDES; MALE; PLATELET ACTIVATION; TIME FACTORS;

EID: 4344676729     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000054369.40802.35     Document Type: Article

References (31)

1. Yan W, Zhao K, Jiang Y, Huang Q, Wang J, Kan W, Wang S: Role of p38 MAPK in ICAM-1 expression of vascular endothelial cells induced by lipopolysaccharide. Shock 17:433-438, 2002.
2. Kuhns DB, Alvord WG, Gallin JI: Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in humans. J Infect Dis 171:145-152, 1995.
3. van Der Poll T, Coyle SM, Levi M, Jansen PM, Dentener M, Barbosa K, Buurman WA, Hack CE, ten Cate JW, Agosti JM, Lowry SF: Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans. Blood 89:3727-3734, 1997.
4. Cowley HC, Heney D, Gearing AJ, Hemingway I, Webster NR: Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: a prospective cohort study. Crit Care Med 22:651-657, 1994.
5. Cummings CJ, Sessler CN, Beall LD, Fisher BJ, Best AM, Fowler AA: Soluble E-selectin levels in sepsis and critical illness. Correlation with infection and hemodynamic dysfunction. Am J Respir Crit Care Med 156:431-437, 1997.
6. Suffredini AF, Reda D, Banks SM, Tropea M, Agosti JM, Miller R: Effects of recombinant dimeric TNF receptor on human inflammatory responses following intravenous endotoxin administration. J Immunol 155:5038-5045, 1995.
7. Kayal S, Jais JP, Chaudiere J, Labrousse J: Elevated circulating E-selectin, intercellular adhesion molecule-1, and von Willebrand Factor in patients with severe infection. Am J Respir Crit Care Med 157:776-784, 1998.
8. Fijnheer R, Frijns CJ, Korteweg J, Rommes H, Peters JH, Sixma JJ, Nieuwenhuis HK: The origin of P-selectin as a circulating plasma protein. Thromb Haemost 77:1081-1085, 1997.
9. Moss M, Gillespie MK, Ackerson L, Moore FA, Moore EE, Parsons PE: Endothelial cell activity varies in patients at risk for the adult respiratory distress syndrome. Crit Care Med 24:1782-1786, 1996.
10. Sakamaki F, Ishizaka A, Handa M, Fujishima S, Urano T, Sayama K, Nakamura H, Kanazawa M, Kawashiro T, Katayama M, et al.: Soluble form of P-selectin in plasma is elevated in acute lung injury. Am J Respir Crit Care Med 151:1821-1826, 1995.
11. Sessler CN, Windsor AC, Schwartz M, Watson L, Fisher BJ, Sugerman HJ, Fowler AA: Circulating ICAM-1 is increased in septic shock. Am J Respir Crit Care Med 151:1420-1427, 1995.
12. Hollenstein U, Homoncik M, Knobl P, Pemerstorfer T, Graggaber J, Eichler HG, Handler S, Jilma B: Acenocoumarol decreases tissue factor-dependent coagulation during systemic inflammation in humans. Clin Pharmacol Ther 71:368-374, 2002.
13. Jilma B, Li-Saw-Hee FI, Wagner OF, Beevers DG, Lip GYH: Effects of enalapril and losartan on circulating adhesion molecules and monocyte chemotactic protein-1 (MCP-1) in hypertensive patients. Clin Sci 103:131-136, 2002.
14. Drexler H, Kurz S, Jeserich M, Munzel T, Hornig B: Effect of chronic angiotensin-converting enzyme inhibition on endothelial function in patients with chronic heart failure. Am J Cardiol 76:13E-18E, 1995.
15. Andersen S, Schalkwijk CG, Stehouwer CD, Parving HH: Angiotensin II blockade is associated with decreased plasma leukocyte adhesion molecule levels in diabetic nephropathy [letter]. Diabetes Care 23:1031-1032, 2000.
16. Gasic S, Wagner OF, Fasching P, Ludwig C, Veitl M, Kapiotis S, Jilma B: Fosinopril decreases levels of soluble vascular cell adhesion molecule-1 in borderline hypertensive type II diabetic patients with microalbuminuria. Am J Hypertens 12:217-222, 1999.
17. Boldt J, Papsdorf M, Kumle B, Piper S, Hempelmann G: Influence of angiotensin-converting enzyme inhibitor enalaprilat on endothelial-derived substances in the critically ill. Crit Care Med 26:1663-1670, 1998.
18. Napoleone E, Di SA, Camera M, Tremoli E, Lorenzet R: Angiotensin- converting enzyme inhibitors downregulate tissue factor synthesis in monocytes. Circ Res 86:139-143, 2000.
19. Sun Z, Andersson R: NF-κB activation and inhibition: a review. Shock 18:99-106, 2002.
20. Kohn G, Wong HR, Bshesh K, Zhao B, Vasi N, Denenberg A, Morris C, Stark J, Shanley TP: Heat shock inhibits TNF-induced ICAM-1 expression in human endothelial cells via Iκ kinase inhibition. Shock 17:91-97, 2002.
21. Suffredini AF, Hochstein HD, McMahon FG: Dose-related inflammatory effects of intravenous endotoxin in humans: evaluation of a new clinical lot of Escherichia coli O:113 endotoxin. J Infect Dis 179:1278-1282, 1999.
22. Santos AA, Wilmore DW: The systemic inflammatory response: perspective of human endotoxemia. Shock 6(Suppl 1):S50-S56, 1996.
23. Pernerstorfer T, Hollenstein U, Hansen J, Knechtelsdorfer M, Stohlawetz P, Graninger W, Eichler HG, Speiser W, Jilma B: Heparin blunts endotoxin-induced coagulation activation. Circulation 100:2485-2490, 1999.
24. Pernerstorfer T, Schmid R, Bieglmayer C, Eichler HG, Kapiotis S, Jilma B: Acetaminophen has greater antipyretic efficacy than aspirin in endotoxemia: a randomized, double-blind, placebo-controlled trial. Clin Pharmacol Ther 66:51-57, 1999.
25. Jilma B, Blann A, Pemerstorfer T, Stohlawetz P, Eichler HG, Vondrovec B, Amiral J, Richter V, Wagner OF: Regulation of adhesion molecules during human endotoxemia. No acute effects of aspirin. Am J Respir Crit Care Med 159:857-863, 1999.
26. Jilma B, Marsik C, Mayr F, Graninger MT, Taylor FBJ, Ribel MC, Erhardtsen E, Handler S, Eichler HG: Pharmacodynamics of active site inhibited factor VIIa (ASIS, FFR-rFVIIa) in endotoxin induced coagulation in humans. Clin Pharmacol Ther 72:403-410, 2002.
27. Blann AD, Lip GY, Beevers DG, McCollum CN: Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers. Thromb Haemost 77:1077-1080, 1997.
28. Wall P, Buising C, Henderson L, Rickers T, Cardenas A, Owens L, Timberlake G, Paradise N: Enalaprilat improves systemic cardiovascular parameters and mesenteric blood flow during hypotensive resuscitation from hemorrhagic shock in dogs. Shock 17:228-233, 2002.
29. Stolley PD, Strom BL: Sample size calculations for clinical pharmacology studies. Clin Pharmacol Ther 39:489-490, 1986.
30. Gomez HJ, Cirillo VJ, Irvin JD: Enalapril: a review of human pharmacology. Drugs 30 (Suppl 1):13-24, 1985.
31. Peeters AC, Netea MG, Kullberg BJ, Thien T, van der Meer JW: The effect of renin-angiotensin system inhibitors on pro- and anti-inflammatory cytokine production. Immunology 94:376-379, 1998.